The ideal Rybelsus patient is someone who already takes a daily medication at a consistent time (like levothyroxine, which also requires empty-stomach dosing), has type 2 diabetes as the primary concern, and strongly prefers to avoid injections
That being said, different mechanisms may offer different side effect profiles, and its possible that future multi-agonists could yield improved tolerability profiles
By targeting both receptors, it regulates insulin secretion, slows down gastric emptying, and suppresses glucagon
Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications prescribed for type 2 diabetes and chronic weight management
Because it acts quickly and does not remain in effect as long, it may be preferred for patients who need immediate but not prolonged relief from excess gastric acid